Observational studyRheumatology international2022

Canakinumab is effective in patients with familial Mediterranean fever resistant and intolerant to the colchicine and/or anakinra treatment.

Yusuf Karabulut et al.PubMed ↗Publisher ↗

No numbers read from the abstract.